Patient Preferences for Biologic and Biosimilar Osteoporosis Treatments in Colombia

Patient Preferences for Biologic and Biosimilar Osteoporosis Treatments in Colombia

Peita L Graham-Clarke,1 Brett Hauber,2 Marco Boeri,3 Felice Leonardi,4 Russel T Burge,5 Maria Fernandez,2 Antje Tockhorn-Heidenreich,6 Sandra Florez4,7 1Global Patient Outcomes and Real World Evidence, Eli Lilly Australia, West Ryde, NSW 2114, Australia; 2Health Preference Assessment Group, RTI Heal...

Full description

Bibliographic Details
Main Authors: Graham-Clarke PL, Hauber B, Boeri M, Leonardi F, Burge RT, Fernandez M, Tockhorn-Heidenreich A, Florez S
Format: Article
Language:English
Published: Dove Medical Press 2020-06-01
Series:Patient Preference and Adherence
Subjects:
discrete-choice experiment
injection
devices
teriparatide
fractures
Online Access:https://www.dovepress.com/patient-preferences-for-biologic-and-biosimilar-osteoporosis-treatment-peer-reviewed-article-PPA

Internet

https://www.dovepress.com/patient-preferences-for-biologic-and-biosimilar-osteoporosis-treatment-peer-reviewed-article-PPA

Similar Items